+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women



Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women



Psychopharmacology 215(3): 429-439



Gender plays a critical role in the effects of drugs and drug abuse liability. Biological factors, including ovarian hormones, may contribute to gender differences in drug abuse. Preclinical and some clinical research suggests that progesterone and its metabolites have activity at the GABA(A) receptor and may enhance the effect of GABAergic compounds (e.g., benzodiazepines). Because women are exposed to varying levels of progesterone from puberty until menopause, and appear more sensitive to the negative consequences of benzodiazepine use, it is important to understand the impact of progesterone on GABAergic drug effects. The purpose of this experiment was to characterize the behavioral effects of progesterone, alone and in combination with the short-acting benzodiazepine, triazolam, to determine if progesterone potentiates the behavioral effects of triazolam. Oral micronized progesterone (0, 100, and 200 mg) and oral triazolam (0.00, 0.12, and 0.25 mg/70 kg) were administered to healthy, premenopausal women (nā€‰=ā€‰11) under conditions of low circulating sex hormones. The subjective, performance and physiological effects of progesterone, alone and in combination with triazolam, were assessed. Triazolam alone produced prototypical sedative-like effects. Progesterone alone also engendered some sedative effects, although the time course of the effects was more limited than that of triazolam. Progesterone increased and extended the duration of triazolam effects and delayed the onset of triazolam peak effects, most notably at the 0.12 mg/70 kg dose. Progesterone potentiates the behavioral effects of benzodiazepines and may contribute to benzodiazepine use and abuse among women.

(PDF emailed within 0-6 h: $19.90)

Accession: 055001690

Download citation: RISBibTeXText

PMID: 21350928

DOI: 10.1007/s00213-011-2206-7


Related references

Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women. Behavioural Pharmacology 22(5-6): 441-449, 2011

The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women. Journal of the Medical Association of Thailand 88 Suppl 3(): S71-S76, 2006

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women. Fertility & Sterility 75(2): 316-323, February, 2001

The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Human Reproduction 20(4): 1090-1099, 2005

A pharmacokinetic evaluation of the effects of thalomid on combination estrogen/progesterone hormones in premenopausal healthy women volunteers. Clinical & Investigative Medicine (SUPPL ): S20, 1998

The effects of single oral doses of 17 beta-oestradiol and progesterone on finger skin circulation in healthy women and in women with primary Raynaud's phenomenon. European Journal of Clinical Pharmacology 46(6): 557-560, 1994

Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women. Psychoneuroendocrinology 37(6): 773-781, 2012

Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. JAMA 265(20): 2688-2691, 1991

Acute effects of triazolam in women: Relationships with progesterone, estradiol and allopregnanolone. Psychopharmacology 130(1): 69-78, 1997

A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women. Journal of the Medical Association of Thailand 93 Suppl 6(): S1-S5, 2011

Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Human Psychopharmacology 18(8): 619-625, 2003

Pharmacokinetic/pharmacodynamic modeling of LH suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women. Clinical Pharmacology & Therapeutics 69(2): P57, February, 2001

Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiology, Biomarkers & Prevention 15(1): 39-44, 2006

Effects of 17,beta estradiol and progesterone on isolated human omental artery from premenopausal nonpregnant women, and from normal and preeclamptic pregnant women. American Journal of Obstetrics & Gynecology 172(1 PART 2): 319, 1995